Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Porphyria, Erythropoietic”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableStudy completedNCT05572125
What this trial is testing

Iron Therapy in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic ProtoporphyriaIron-deficiency
Bispebjerg Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 150
Not applicableStudy completedNCT01688895
What this trial is testing

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-Linked Protoporphyria+5 more
Icahn School of Medicine at Mount Sinai 150
Not applicableLooking for participantsNCT04883905
What this trial is testing

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Who this might be right for
Acute Hepatic Porphyria
Alnylam Pharmaceuticals 150
Not applicableUnknownNCT00004331
What this trial is testing

Studies in Porphyria I: Characterization of Enzyme Defects

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 25
Not applicableEnded earlyNCT03547297
What this trial is testing

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Who this might be right for
Acute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more
Alnylam Pharmaceuticals 212
Not applicableActive Not RecruitingNCT05344599
What this trial is testing

Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

Who this might be right for
Postural Orthostatic Tachycardia SyndromeAcute Hepatic Porphyria
Vanderbilt University Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT06388642
What this trial is testing

Pharmacokinetics of Afamelanotide in EPP Patients

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Europe Limited 28
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Early research (Phase 1)Study completedNCT00004397
What this trial is testing

Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 20
Not applicableStudy completedNCT03906214
What this trial is testing

Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

Who this might be right for
Porphyrias
University of South Florida 60
Large-scale testing (Phase 3)Study completedNCT03338816
What this trial is testing

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

Who this might be right for
Acute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more
Alnylam Pharmaceuticals 94
Not applicableApproved For MarketingNCT04056481
What this trial is testing

Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria

Who this might be right for
Acute Hepatic Porphyria
Alnylam Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02180412
What this trial is testing

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

Who this might be right for
Acute Porphyrias
The University of Texas Medical Branch, Galveston 20
Not applicableStudy completedNCT00004831
What this trial is testing

Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
FDA Office of Orphan Products Development 20
Testing effectiveness (Phase 2)Study completedNCT00004396
What this trial is testing

Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 32
Testing effectiveness (Phase 2)Ended earlyNCT02922413
What this trial is testing

Panhematin for Prevention of Acute Attacks of Porphyria

Who this might be right for
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
The University of Texas Medical Branch, Galveston 13
Testing effectiveness (Phase 2)Study completedNCT05020184
What this trial is testing

Effect of Oral Cimetidine in the Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaX-linked Protoporphyria
Amy K. Dickey, M.D. 26
Testing effectiveness (Phase 2)Study completedNCT00004789
What this trial is testing

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 59
Large-scale testing (Phase 3)Study completedNCT00599326
What this trial is testing

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
University of Texas Southwestern Medical Center 10
Load More Results